突发公告后，600745最新回应

Core Viewpoint - The company firmly defends its legal rights and criticizes the Dutch government's actions against Nexperia as politically motivated and discriminatory towards Chinese enterprises [4][10]. Group 1: Company Response - The company condemns the Dutch government's decision to freeze Nexperia's global operations under the pretext of "national security," arguing it is an excessive intervention based on geopolitical bias rather than factual risk assessment [4]. - The company expresses strong opposition to the actions of certain foreign executives attempting to alter Nexperia's ownership structure through legal means, viewing it as a political maneuver to undermine shareholder rights and disrupt the company's governance [4][10]. Group 2: Financial Performance and Achievements - Following the acquisition of Nexperia, the company has significantly improved its operational quality, with Nexperia's revenue reaching a peak of €2.36 billion in 2022 and gross margin increasing from 25% in 2020 to 42.4% in 2022 [5]. - Nexperia is projected to achieve a "zero debt" status by October 2024, having repaid all prior debts [5]. - Research and development investments have steadily increased from €112 million in 2019 to €284 million in 2024, with a growing proportion of capitalized expenditures [5]. - The number of new global patent applications has surged, with 95 applications in 2023 and a projected 110 in 2024, compared to an average of 10-15 annually before 2019 [5]. Group 3: Legal and Diplomatic Actions - The company has initiated all necessary legal and diplomatic measures to demand the immediate withdrawal of the Dutch government's erroneous directive and to stop systemic discrimination against Chinese enterprises [10]. - The company emphasizes the importance of a collaborative rather than confrontational approach in the global semiconductor industry, advocating for a fair and non-discriminatory business environment [10].